205 related articles for article (PubMed ID: 17321748)
21. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
[TBL] [Abstract][Full Text] [Related]
22. Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes.
Pihlaja R; Koistinaho J; Kauppinen R; Sandholm J; Tanila H; Koistinaho M
Glia; 2011 Nov; 59(11):1643-57. PubMed ID: 21826742
[TBL] [Abstract][Full Text] [Related]
23. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
24. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition.
Akiyama H; Kondo H; Ikeda K; Kato M; McGeer PL
Brain Res; 2001 Jun; 902(2):277-81. PubMed ID: 11384622
[TBL] [Abstract][Full Text] [Related]
26. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA
Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566
[TBL] [Abstract][Full Text] [Related]
27. Aβ secretion and plaque formation depend on autophagy.
Nilsson P; Loganathan K; Sekiguchi M; Matsuba Y; Hui K; Tsubuki S; Tanaka M; Iwata N; Saito T; Saido TC
Cell Rep; 2013 Oct; 5(1):61-9. PubMed ID: 24095740
[TBL] [Abstract][Full Text] [Related]
28. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
29. [Novel Abeta-converting activity of angiotensin-converting enzyme and its role in Alzheimer's disease].
Zou K; Michikawa M; Komano H
Seikagaku; 2010 Dec; 82(12):1120-4. PubMed ID: 21348266
[No Abstract] [Full Text] [Related]
30. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.
Park JH; Gimbel DA; GrandPre T; Lee JK; Kim JE; Li W; Lee DH; Strittmatter SM
J Neurosci; 2006 Feb; 26(5):1386-95. PubMed ID: 16452662
[TBL] [Abstract][Full Text] [Related]
31. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
[TBL] [Abstract][Full Text] [Related]
32. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Kehoe PG; Wilcock GK
Lancet Neurol; 2007 Apr; 6(4):373-8. PubMed ID: 17362841
[TBL] [Abstract][Full Text] [Related]
33. Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.
Zou K; Maeda T; Watanabe A; Liu J; Liu S; Oba R; Satoh Y; Komano H; Michikawa M
J Biol Chem; 2009 Nov; 284(46):31914-20. PubMed ID: 19773553
[TBL] [Abstract][Full Text] [Related]
34. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
[TBL] [Abstract][Full Text] [Related]
35. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease.
Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I
Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315
[TBL] [Abstract][Full Text] [Related]
36. Intracerebroventricular passive immunization with anti-oligoAbeta antibody in TgCRND8.
Chauhan NB
J Neurosci Res; 2007 Feb; 85(2):451-63. PubMed ID: 17086547
[TBL] [Abstract][Full Text] [Related]
37. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
38. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
40. Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme.
Miners JS; van Helmond Z; Kehoe PG; Love S
Brain Pathol; 2010 Jul; 20(4):794-802. PubMed ID: 20175776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]